[
    [
        {
            "time": "2019-04-11",
            "original_text": "中银国际*每日速递20190411：通信边缘计算行业专题；拓邦股份、建研集团、当升科技、益丰药房、吉比特、超图软件等",
            "features": {
                "keywords": [
                    "益丰药房",
                    "高增长",
                    "门店扩张"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中银国际*每日速递20190411：通信边缘计算行业专题；拓邦股份、建研集团、当升科技、益丰药房、吉比特、超图软件等",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-03",
            "original_text": "报告| 2019年3月湖南省A股上市公司市值排行榜",
            "features": {
                "keywords": [
                    "益丰药房",
                    "市值",
                    "排名"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "报告| 2019年3月湖南省A股上市公司市值排行榜",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "太平洋证券今日早读】傲农生物深度报告|华新水泥、益丰药房、拓斯达、伟明环保公司点评20190411",
            "features": {
                "keywords": [
                    "益丰药房",
                    "业绩点评",
                    "整合能力",
                    "高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "太平洋证券今日早读】傲农生物深度报告|华新水泥、益丰药房、拓斯达、伟明环保公司点评20190411",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018",
            "original_text": "【国元医药】益丰药房2018年报点评：门店扩张加快，精细化管理赋予确定性增速",
            "features": {
                "keywords": [
                    "益丰药房",
                    "门店扩张",
                    "精细化管理",
                    "高增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国元医药】益丰药房2018年报点评：门店扩张加快，精细化管理赋予确定性增速",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019",
            "original_text": "门店翻倍 营业额暴增44%！益丰持续大并购",
            "features": {
                "keywords": [
                    "益丰药房",
                    "并购",
                    "营业额增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "门店翻倍 营业额暴增44%！益丰持续大并购",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "【医药|杜佐远团队太平洋证券】益丰药房(603939)：18年&19Q1业绩点评：强大整合能力助力业绩高速增长",
            "features": {
                "keywords": [
                    "益丰药房",
                    "整合能力",
                    "业绩增长"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药|杜佐远团队太平洋证券】益丰药房(603939)：18年&19Q1业绩点评：强大整合能力助力业绩高速增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019",
            "original_text": "益丰药房:门店增长迅速,业绩维持高速增长",
            "features": {
                "keywords": [
                    "益丰药房",
                    "门店增长",
                    "业绩增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "益丰药房:门店增长迅速,业绩维持高速增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]